|

P-CD19CD20-ALLO1 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • Poseida Therapeutics, Inc.1

Indications

  • DLBCL NOS1
  • DLBCL, Diffused Large B Cell Lymphoma1
  • DLBCL Arising From Follicular Lymphoma1
  • Transformed Follicular Lymphoma (tFL)1
  • Follicular Lymphoma Grade 3B1

La Jolla, California1 trial

P-CD19CD20-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With B Cell Malignancies

University of California San Diego

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.